Tags

, , ,

In recent years, frontline treatments for Plasmodium falciparum malaria have been failing in parts of southeast Asia, a historic epicentre for the emergence and spread of antimalarial drug resistance.The current treatment for P falciparum consists of a fast-acting artemisinin derivative and a longer-acting partner drug, termed artemisinin combination therapy. Dihydroartemisinin with piperaquine has been the artemisinin combination therapy of choice in Cambodia, Thailand, and Vietnam for lengthy periods during the past decade. By 2008, parasites in western Cambodia began developing resistance to…………………………….continue readinghttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30392-5/fulltext?rss=yes&utm_campaign=update-laninf&utm_source=hs_email&utm_medium=email&utm_content=74915801&_hsenc=p2ANqtz-822OBLJjgDPiO_5h6ko7Ti9tU6fyPBIQa-aD14d4N5YwUOj6r8pUOT5MKKJe1bjrlcHHpE-AdRRf9wzSQVAvWczk0e1w&_hsmi=74915801

Advertisements